report
case
ebv
enceph
sevenyrold
child
ph
two
month
allogen
hsct
hla
mismatch
mother
patient
show
alter
sensorium
gener
seizur
left
hemiparesi
brain
mri
demonstr
multipl
lesion
highli
suggest
viral
enceph
blood
csf
pcr
analys
neg
common
virus
involv
immunocompromis
patient
includ
ebv
cerebr
biopsi
perform
show
intens
gliosi
perivascular
lymphocyt
cuf
pcr
analysi
perform
brain
tissu
posit
ebv
genom
extens
investig
viral
infect
neg
patient
neurolog
symptom
rapidli
worsen
die
two
month
later
case
report
suggest
patient
present
neurolog
radiolog
sign
enceph
hsct
ebv
involv
consid
even
absenc
csf
blood
pcr
viru
detect
wide
rang
pathogen
includ
virus
caus
enceph
hsct
patient
ebv
enceph
describ
rare
event
posthsct
set
report
frequenc
among
viral
etiolog
ptld
wellknown
lifethreaten
diseas
restrict
cn
repres
frequent
neurolog
complic
ebv
infect
follow
transplant
nonetheless
enceph
must
consid
differenti
diagnosi
enceph
suspect
patient
present
typic
clinic
sign
inflammatori
cell
present
csf
chang
brain
imag
suggest
inflamm
last
year
detect
ebv
dna
csf
becom
gold
standard
diagnosi
ebv
cn
infect
ebvassoci
cn
lymphoma
viral
dna
detect
csf
repres
diagnost
standard
clinic
practic
consid
brain
biopsi
may
associ
signific
morbid
intracrani
hemorrhag
biopsi
site
edema
although
incid
seriou
advers
event
diminish
use
modern
stereotact
approach
herein
present
case
leukem
child
develop
ebv
enceph
hsct
diagnos
brain
biopsi
virolog
investig
csf
repeatedli
neg
low
level
ebv
dna
detect
peripher
blood
knowledg
first
observ
report
similar
discrep
ebv
infect
sevenyrold
child
ph
second
complet
hematolog
remiss
underw
hsct
mother
hla
compat
hlaa
mismatch
novemb
recipi
donor
ebvigg
seroposit
igm
seroneg
condit
regimen
includ
thiotepa
mgkgday
day
fludarabin
mg
day
day
busulfan
mgkg
day
day
atg
mgkgday
day
tcell
replet
bone
marrow
graft
contain
total
nuclear
cell
kg
cellskg
cellskg
infus
day
cyclosporin
short
cours
methotrex
given
gvhd
prophylaxi
engraft
achiev
day
full
donor
chimer
day
asymptomat
cmv
viremia
detect
quantit
realtim
pcr
method
cmv
dna
level
blood
cpml
preemptiv
therapi
foscarnet
mgkg
everi
h
start
day
persist
blood
viral
replic
cpml
treatment
modifi
ad
ganciclovir
mgkgday
foscarnet
mgkgday
blood
cmv
dna
level
becam
undetect
day
one
wk
later
antivir
treatment
discontinu
day
patient
present
biopsyproven
bilater
testicular
relaps
bone
marrow
aspir
show
morpholog
remiss
full
donor
chimer
still
maintain
bilater
testicular
radiotherapi
start
initi
respons
januari
day
child
develop
fever
headach
dysuria
time
white
blood
cell
count
l
neutrophil
lymphocyt
hemoglobin
level
gdl
platelet
count
l
chemistri
panel
liver
function
test
within
normal
rang
baselin
serum
cyclosporin
level
ngml
activ
gvhd
present
intraven
antibacteri
treatment
piperacillintazobactam
ciprofloxacin
promptli
start
day
present
vomit
alter
sensorium
follow
gener
tonicclon
seizur
success
treat
midazolam
left
hemiplegia
present
clinic
examin
brain
mri
perform
day
reveal
multipl
lesion
right
hemispher
particular
area
involv
cerebr
cortex
ipocortex
frontalinsular
region
character
restrict
diffus
hypointens
adc
imag
normal
intens
flair
imag
lesion
display
hyperintens
hypointens
involv
basal
ganglia
associ
compress
later
ventricl
anoth
area
featur
present
midbrain
lesion
show
abnorm
contrast
enhanc
fig
mri
imag
highli
suggest
viral
enceph
csf
examin
show
lymphocyt
pleocytosi
cellsll
increas
protein
level
mgdl
normal
rang
slightli
increas
glucos
level
mgdl
normal
rang
malign
cell
found
cytolog
flowcytometri
analysi
oligoclon
igg
band
absent
base
suspicion
viral
enceph
cyclosporin
stop
treatment
dexamethason
mgm
everi
six
h
foscarnet
mgkg
everi
h
immedi
start
addit
valproic
acid
anticonvuls
drug
intraven
antibacteri
treatment
continu
polyval
immunoglobulin
mgkgdose
administ
plan
everi
two
wk
subsequ
day
result
csf
pcr
analysi
show
absenc
dna
cmv
ebv
vzv
jcv
bkv
rna
enterovirus
addit
csf
cultur
serolog
test
bacteria
mycobacteria
fungi
toxoplasma
neg
time
ebvpcr
peripher
blood
neg
ebvdna
load
monitor
everi
two
wk
display
low
level
two
circumst
copiesml
day
respect
four
day
later
child
present
continu
epilepsi
progress
conscious
impair
refer
pediatr
icu
repeat
mri
document
extens
frontalinsular
lesion
hypointens
adc
slight
hyperintens
flair
imag
fig
eeg
show
diffus
slow
consist
enceph
anticonvuls
phenytoin
ad
treatment
despit
treatment
foscarnet
dexamethason
patient
show
clinic
improv
day
two
wk
onset
neurolog
symptom
second
lumbar
punctur
perform
attempt
identifi
caus
agent
enceph
csf
examin
normal
cellular
sediment
glucos
level
mgdl
protein
level
mgdl
pcrcsf
analys
confirm
absenc
dna
cmv
ebv
vzv
patient
experienc
progress
deterior
neurolog
function
requir
intub
mechan
ventil
eeg
monitor
document
worsen
bioelectr
pattern
mri
reveal
extens
inflammatori
lesion
also
involv
right
pariet
cortex
left
frontalinsular
region
fig
day
absenc
neurolog
improv
foscarnet
stop
treatment
aciclovir
mgkg
everi
eight
h
intraven
start
day
irrevers
progress
brain
damag
without
recogn
viral
etiolog
led
us
perform
stereotact
biopsi
show
damag
parenchyma
reactiv
gliosi
microgli
activ
inflammatori
cellular
infiltr
fig
b
alter
highlight
intens
immunoreact
gfap
fig
infiltr
small
lymphocyt
show
featur
atypia
eg
irregular
fold
nuclei
condens
chromatin
inconspicu
nucleoli
scant
cytoplasm
present
singl
cell
around
vessel
major
cell
posit
blymphoid
cell
scant
fig
f
morpholog
immunophenotyp
featur
tcell
infiltr
marker
glial
activ
consist
infectiousinflammatori
process
compat
diagnosi
ebvassoci
tcell
ptld
immunohistochem
studi
monoclon
antibodi
ebv
posit
presenc
ebv
brain
tissu
assess
qpcr
dna
extract
ffpe
tissu
specimen
use
qiaamp
dna
blood
mini
kit
qiagen
hilden
germani
presenc
ebv
per
cell
establish
use
ebv
rgene
kit
cell
control
rgene
obtain
argen
verniol
franc
analysi
detect
cell
ebv
brain
tissu
time
nucleic
acid
detect
brain
tissu
cmv
hsv
vzv
htlv
parvoviru
bkv
jcv
measl
mump
enterovirus
respiratori
virus
influenza
parainfluenza
respiratori
syncyti
viru
human
metapneumoviru
rhinoviru
adenoviru
novel
human
coronaviru
neg
pcr
analysi
parallel
peripher
blood
sampl
neg
ebv
well
aforement
virus
featur
prompt
us
final
diagnosi
ebvrel
enceph
antivir
treatment
modifi
replac
aciclovir
ganciclovir
mgkg
everi
h
day
time
hematolog
relaps
bone
marrow
ph
blast
diagnos
daili
dasatinib
therapi
dosag
mgm
day
given
nasogastr
tube
despit
antivir
antileukem
treatment
patient
experienc
deterior
neurolog
function
progress
hematolog
diseas
expir
day
transplant
autopsi
perform
case
show
diagnosi
ebv
enceph
hypothes
highli
immunosuppress
patient
present
unspecif
neurolog
symptom
even
absenc
ebv
detect
csf
without
signific
system
reactiv
virolog
result
obtain
patient
repres
uncommon
find
accord
literatur
detect
ebv
dna
csf
concomit
low
level
neg
dna
result
obtain
peripher
blood
patient
deep
ebvassoci
diseas
report
patient
diagnosi
isol
cnsptld
contrari
surpris
patient
ebvpcr
neg
two
consecut
csf
sampl
despit
extens
biopsyproven
ebv
enceph
ebv
infect
b
cell
tissu
biopsi
contain
b
cell
may
posit
ebv
pcr
may
explain
posit
pcr
tissu
biopsi
neg
csf
howev
case
discrep
justifi
pleocytosi
predomin
lymphocyt
present
csf
moreov
high
viral
load
copi
per
cell
detect
pcr
brain
biopsi
favor
hypothesi
viral
replic
bcell
contamin
brain
parenchyma
nevertheless
falseneg
pcr
result
csf
peripher
blood
could
exclud
falseneg
case
ascrib
mani
factor
includ
low
amount
viral
dna
test
sampl
presenc
pcr
inhibitor
common
compon
clinic
sampl
eg
hemoglobin
heparin
igg
ineffect
releas
viral
dna
cell
poor
dna
recoveri
extract
purif
step
moreov
case
earli
stage
hsv
enceph
children
immunocompromis
patient
cell
found
csf
hsv
pcr
neg
occasion
report
knowledg
first
observ
report
similar
discrep
ebv
infect
inform
obtain
examin
csf
peripher
blood
may
mislead
hsct
patient
acut
neurolog
symptom
neuroimag
repres
current
key
part
investig
process
enceph
fact
locat
lesion
within
brain
may
use
differenti
diagnosi
inde
ebv
characterist
tropism
area
cerebr
hemispher
basal
ganglia
cerebellum
brain
stem
thalamu
limbic
system
order
frequent
involv
howev
mri
imag
csf
find
suggest
enceph
inconclus
etiolog
diagnosi
brain
stereotact
biopsi
consid
order
provid
direct
evid
brain
involv
specif
infecti
process
exclud
mani
noninfecti
altern
diagnos
obtain
diagnosi
viral
enceph
relev
ensur
prompt
initi
specif
treatment
nevertheless
current
limit
evid
effect
therapi
ebv
enceph
posttranspl
continu
challeng
clinic
problem
consist
poor
outcom
particular
efficaci
antivir
drug
ebv
enceph
debat
success
treatment
intraven
ganciclovir
report
case
ebvassoci
enceph
case
ad
stage
late
evalu
efficaci
howev
patient
treat
onset
symptom
foscarnet
highli
activ
drug
ebv
fact
argu
efficaci
effect
antivir
drug
ebv
enceph
least
patient
conclus
case
show
aggress
diagnost
approach
transplant
patient
includ
brain
biopsi
select
case
need
pursu
earli
diagnosi
set
clinic
radiograph
evid
consist
viral
enceph
csf
analysi
identifi
etiolog
